United States — Total Revenue
Moderna United States — Total Revenue remained flat by 0.0% to $299.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 32.8%, from $446.25M to $299.75M. Over 4 years (FY 2021 to FY 2025), United States — Total Revenue shows a downward trend with a -33.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful product adoption or market expansion in the U.S., while a decrease may indicate heightened competition, loss of patent exclusivity, or reduced demand for the company's therapeutic offerings.
Detailed definition
This metric represents the total gross income generated from the sale of goods and services within the United States geo...
Peer comparison
Peers in the biotechnology sector typically report geographic revenue splits to highlight regional market penetration and dependency on specific regulatory environments.
mrna_segment_united_states_total_revenueHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $6.18B | $5.15B | $1.90B | $1.79B | $1.20B |
| YoY Change | — | -16.6% | -63.2% | -5.8% | -32.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Moderna's united states — total revenue?
- Moderna (MRNA) reported united states — total revenue of $299.75M in Q4 2025.
- How has Moderna's united states — total revenue changed year-over-year?
- Moderna's united states — total revenue decreased by 32.8% year-over-year, from $446.25M to $299.75M.
- What is the long-term trend for Moderna's united states — total revenue?
- Over 4 years (2021 to 2025), Moderna's united states — total revenue has grown at a -33.6% compound annual growth rate (CAGR), from $6.18B to $1.20B.
- What does united states — total revenue mean?
- Total sales revenue earned specifically from customers located in the United States.